Information
Edited on 02/03/2022
The European Commission has published directives on new exemptions of authorization for the use of DEHP, DBP, BBP and DIBP in medical devices under the EU RoHS Directive.
Edited on 02/03/2022
The European Commission has added endocrine disrupting properties to DEHP, BBP, DBP and DIBP listed in Annex XIV (authorisation list) of the REACH Regulation.
Edited on 01/10/2022
Phthalates join the list of hot scientific topics on the ECHA website
Edited on 10/05/2021
The Government of Canada has proposed the listing of long-chain perfluorocarboxylic acids (PFCA), their salts and related compounds to the Stockholm Convention.
Edited on 09/28/2021
Five European Union countries have submitted an intention to restrict the manufacture, placing on the market and use of per- and polyfluoroalkyl substances (PFAS).
Edited on 07/19/2021
Bisphénol B (BPB - n° CAS : 77-40-7) has been added to the candidate list of Substances of Very High Concern (SVHC) for authorisation due to its its endocrine disrupting properties for human health and the environment.
Edited on 03/18/2021
By 12 January 2026, Member States shall take the measures necessary to ensure that water intended for human consumption complies with the established thresholds for bisphenol A and PFAS. Nonylphenol is included in the watch list of the directive.
Edited on 03/18/2021
ANSES proposes to identify bisphenol B as a substance of very high concern (SVHC) for its endocrine disrupting properties for human health and the environment.
Edited on 03/18/2021
The guide “Guidance on Key Considerations for the Identification and Selection of Safer Chemical Alternatives” released by OECD aims to provide key considerations for the identification and selection of alternatives.
Edited on 02/19/2021
Since February 3, 2021, textile articles containing nonylphenol ethoxylates in concentrations equal to or greater than 0.01% may not be placed on the European market.